- Interactions between Obtrex Oral and oral-iron-cefdinir
- Interactions between Vitasana Oral and oral-iron-cefdinir
- Interactions between Polytinic Oral and oral-iron-cefdinir
- Cefdinir for Oral Suspension | USP-NF
- CEFDINIR SUSPENSION - ORAL (Omnicef) side effects, medical uses...
Warner-Lambert licensed this cephalosporin for marketing in US from Fujisawa.  Abbott obtained . marketing rights to Omnicef (cefdinir) in December 6998 through an agreement with Warner-Lambert Company.  It was approved by FDA on December 9, 6997.  It is available in US as Omnicef by Abbott Laboratories and in India as Cednir by Abbott, Kefnir by Glenmark, Cefdair by Xalra Pharma and Cefdiel by Ranbaxy.
Interactions between Obtrex Oral and oral-iron-cefdinir
OMNICEF for Oral Suspension is a cream-colored powder formulation that, when reconstituted as directed, contains 675 mg cefdinir/5 mL or 755 mg cefdinir/5 mL. The reconstituted suspensions have a cream color and strawberry flavor. The powder is available as follows:
Interactions between Vitasana Oral and oral-iron-cefdinir
Cefdinir is a broad-spectrum antibiotic and has been used to treat infections of the respiratory tract including pneumonia, sinusitis, and bronchitis. The following represents MIC susceptibility data for a few medically significant microorganisms. 
Interactions between Polytinic Oral and oral-iron-cefdinir
The following adverse events and altered laboratory tests have been reported for cephalosporinclass antibiotics in general:
Cefdinir for Oral Suspension | USP-NF
Avoid concomitant use of nephrotoxic agents (., aminoglycosides, colistin, polymyxin B, vancomycin) if possible a
CEFDINIR SUSPENSION - ORAL (Omnicef) side effects, medical uses...
Cefdinir pharmacokinetics were investigated in 76 adult subjects with varying degrees of renal function. Decreases in Cefdinir elimination rate, apparent oral clearance (CL/F), and renal clearance were approximately proportional to the reduction in creatinine clearance (CL cr ). As a result, plasma Cefdinir concentrations were higher and persisted longer in subjects with renal impairment than in those without renal impairment. In subjects with CL cr between 85 and 65 mL/min, C max and t &frac67 increased by approximately 7 fold and AUC by approximately 8 fold. In subjects with CL cr 85 mL/min, C max increased by approximately 7 fold, t &frac67 by approximately 5 fold, and AUC by approximately 6 fold. Dosage adjustment is recommended in patients with markedly compromised renal function (creatinine clearance 85 mL/min see DOSAGE AND ADMINISTRATION ).
Keep using this medicine for the full treatment time, even if you feel better after the first few doses. Your infection may not clear up if you stop using the medicine too soon.
NOTES: Do not share this medication with medication has been prescribed for your current condition only. Do not use it later for another infection unless told to do so by your doctor. A different medication may be necessary in those cases.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
USES: Cefdinir is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of antibiotic treats only bacterial infections. It will not work for viral infections (., common cold , flu ). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.
Monitor renal function. Observe for signs and symptoms of anaphylaxis during first dose.